Development of a Novel CD4 + TCR Transgenic Line That Reveals a Dominant Role for CD8 + Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria
We describe an MHC class II (I-A )-restricted TCR transgenic mouse line that produces CD4 T cells specific for species. This line, termed PbT-II, was derived from a CD4 T cell hybridoma generated to blood-stage ANKA (PbA). PbT-II cells responded to all species and stages tested so far, including rod...
Saved in:
Published in | The Journal of immunology (1950) Vol. 199; no. 12; pp. 4165 - 4179 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association of Immunologists
15.12.2017
AAI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We describe an MHC class II (I-A
)-restricted TCR transgenic mouse line that produces CD4
T cells specific for
species. This line, termed PbT-II, was derived from a CD4
T cell hybridoma generated to blood-stage
ANKA (PbA). PbT-II cells responded to all
species and stages tested so far, including rodent (PbA,
NK65,
AS, and
17XNL) and human (
) blood-stage parasites as well as irradiated PbA sporozoites. PbT-II cells can provide help for generation of Ab to
infection and can control this otherwise lethal infection in CD40L-deficient mice. PbT-II cells can also provide help for development of CD8
T cell-mediated experimental cerebral malaria (ECM) during PbA infection. Using PbT-II CD4
T cells and the previously described PbT-I CD8
T cells, we determined the dendritic cell (DC) subsets responsible for immunity to PbA blood-stage infection. CD8
DC (a subset of XCR1
DC) were the major APC responsible for activation of both T cell subsets, although other DC also contributed to CD4
T cell responses. Depletion of CD8
DC at the beginning of infection prevented ECM development and impaired both Th1 and follicular Th cell responses; in contrast, late depletion did not affect ECM. This study describes a novel and versatile tool for examining CD4
T cell immunity during malaria and provides evidence that CD4
T cell help, acting via CD40L signaling, can promote immunity or pathology to blood-stage malaria largely through Ag presentation by CD8
DC. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 D.F.-R. designed and performed the research and wrote the manuscript; L.S.L., N.G., C.M.J., W.Y.N., G.M.D., D.B., L.H., Y.K., G.B., S.H.H., K.R.J., M.H.E., L.I.M.L., J.A.E., and M.S.F.S. performed research; A.C., V.M., T.F.d.K.-W., P.R.G., A.D.U., C.J.T., T.K., and G.I.M. provided reagents; A.H., B.S.C., and F.R.C. designed the research; W.R.H. designed the research and wrote the manuscript. |
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.1700186 |